Chapter 31. Second Generation Antisense Oligonucleotides: 2′-Modifications

Annual Reports in Medicinal Chemistry

Volumn 33, Issue C, 1998, Pages 313-325

  Cook, P Dan ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956770649     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)61096-9     Document Type: Chapter

References (64)

1. Cook P.D. In: Crooke S.T. (Ed). "Handbook of Experimental Pharmacology" (1998), Springer-Verlag, Heidelberg, Germany
2. Slichenmyer, W.J., in "Antisense DNA & RNA Based Therapeutics, 5th International Conference, Coronado, CA, International Business Communications Abstracts," Southborough, MA (1998)
3. Kisner, D.L., in "Antisense DNA & RNA Based Therapeutics, 5th International Conference, Coronado, CA, International Business Communications Abstracts", Southborough, MA (1998)
4. Miller P.S., and Ts'o P.O.P. Annu. Rep.Med. Chem. 23 (1998) 295
5. Matteucci M.D., and Bischofberger N. Annu. Rep.Med. Chem. 26 (1991) 287
6. Kiely J.S. Annu. Rep.Med. Chem. 29 (1994) 297
7. Anderson, K.P., Fox, M.C., Brown-Driver, V. & Martin, M.J., Antimicrobial Agents Chemother., Sept 1996, 2004 (1996)
8. Muccioli, C., Goldstein, D.A., Johnson, D.W., Perez, J.E., Mora-Duarte, J.F., Sheppard, J.D., Mansour, S.E., Chan, C.K., Palestine, A.G. and Grillone, L.R., 5th Conference on Retroviruses and Opportunistic Infections, 224 (1998)
9. Bennett C.F., Dean N., Ecker D.J., and Monia B.P. In: Agrawal S. (Ed). "Methods in Molecular Medicine: Antisense Therapeutics" (1996), Humana Press, Totowa, NJ 13-46
10. Yacyshvn, B., Woloschuk, B., Yacyshyn, M.B., Martini, D., Tami, J., Bennett, F., Kisner, D. and Shanahan, W., Gastroentrology., accepted (1998)
11. Isis Pharmaceuticals, Press release, December 28, 1995, Contact Jane Green, (619)-603-3880, info@isisph.com
12. Hybridon Inc., Press release, July 25, 1997, Contact Robin Hogan, (617)-528-7504, info@hybridon.com
13. Zon, G., in, "Antisense DNA & RNA Based Therapeutics", 5th International Conference, Coronado, CA, International Business Communications Abstracts", Southborough, MA (1998)
14. Presented at Gene Therapy Symposium, Hammersmith Hospitial, London England, Genta Incorporated, Press release, July 2, 1996, (619)-455-2700, genta@genta.com
15. Friesen, A.D., in "Antisense DNA & RNA Based Therapeutics, 5th International Conference, Coronado, CA, International Business Communications Abstracts", Southborough, MA (1998)
16. Gewirtz, A.M., in "Oligonucleotides as Therapeutic Agents", Ciba Foundation Symposium 209, J. Wiley & Sons, NY, NY, p. 169-191 (1997)
17. Freier S. In: Crooke S.T., and Lebleu B. (Eds). "Antisense Research and Applications (1993), CRC Press, Boca Raton, FL 67-82
18. Freier S.M., Lima W.F., Sanghvi Y.S., Vickers T., Zounes M., Cook P.D., and Ecker D.J. In: Erickson R.P., and Izant J.G. (Eds). "Gene Regulation: Biology of Antisense RNA and DNA" (1992), Raven Press, City & State 95-107 Mol. Cell.Biol. Series
19. Lesnik E.A., Guinosso C.J., Kawasaki A.M., Sasmor H., Zounes M., Cummins L.L., Ecker D.J., Cook P.D., and Freier S.M. Biochemistry 32 (1993) 7832
20. Agrawal S., Zhang X., Lu Z., Zhao H., Tamburin J.M., Yan J., Cai H., Diasio R.B., Habus I., Jiang Z., Iyer R.P., Yu D., and Zhang R. Biochem. Pharmacol. 50 (1995) 571
21. Agrawal S., Jiang Z., Zhao Q., Shaw D., Sun D., and Saxinger C. Nucleosides Nucelotides 16 7-9 (1997) 927
22. Greig M.J., Gaus H., Cummins L.L., Sasmor H., and Griffey R.H. J. Am. Chem.Soc. 117 (1995) 10765
23. Henry S.P., Zuckerman J.E., Rojko J., Hall W.C., Harman R.J., Kitchen D., and Crooke S.T. Anti-Cancer Drug Design 12 (1997)
24. Agrawal S. Tibtech 14 (1996)
25. Henry S.P., Monteith D., Bennett F., and Levin A.A. Anti-Cancer Drug Design 12 (1997) 409
26. Gao W.Y., Han F.S., Storm C., Egan W., and Cheng Y.C. Mol. Pharmacol. 41 (1992) 223
27. Wallace T.L., Bazemore S.A., Kornbrust D.J., and Cossum P.A. J. Pharm. Exper.Therapeutics 278 (1996) 1306
28. Henry S.P., Zuckerman J.E., Rojko J., Hall W.C., Harman R.J., Kitchen D., and Crooke S.T. Anti-Cancer Drug Deisgn 12 (1997) 1
29. Agrawal S., Zhao Q., Jiang Z., Oliver C., Giles H., Heath J., and Serota D. Antisense Nucleic Acid Drug Dev. 7 6 (1997) 575-584
30. Herdewijn P. Liebigs Ann. (1996) 1337
31. Lesnik E.A., and Freier S.M. Biochemistry 34 34 (1995) 10807
32. Cook P.D. Anti-Cancer Drug Design 6 (1991) 585
33. Freier S.M., and Altmann K.-H. Nucleic Acids Res. 25 (1997) 4429
34. Lesnik E.A., Guinosso C.J., Kawasaki A.M., Sasmor H., Zounes M., Cummins L.L., Ecker D.J., Cook P.D., and Freier S.M. Biochemistry 32 (1993) 7832
35. Cummins L.L., Owens S.R., Risen L.M., Lesnik E.A., Freier S.M., McGee D., Guinosso C.J., and Cook P.D. Nucleic Acids Res. 23 (1995) 2019
36. Griffey R.H., Lesnik E., Freier S., Sanghvi Y.S., Teng K., Kawasaki A., Guinosso C., Wheeler P., Mohan V., and Cook P.D. In: Sanghvi Y.S., and Cook P.D. (Eds). "Carbohydrate Modifications in Antisense Research" (1994), American Chemical Society, Washington, DC 212-224 ACS Symposium Series No. 580
37. Schmit C., Bévierre M.O., De Mesmaeker A., and Altmann K.-H. Bioorg. Med.Chem. Lett. 4 (1994) 1969
38. Altmann K.-H., Dean N.M., Fabbro D., Freier S.M., Geiger T., Häner R., Sasmor H., and Moser H.E. Chima 50 (1996) 168
39. Altmann K.-H., Kesselring R., and Pieles U. Tetrahedron 52 (1996) 12699
40. Egli M. Angev. Chem.Int. Ed.Engl. 35 (1996) 1894
41. Griffey R.H., Monia B.P., Cummins L.L., Freier S., Greig M.J., Guinosso C.J., Lesnik E., Manalili S.M., Mohan V., Owens S., Ross B.R., Sasmor H., Wancewicz E., Weiler K., Wheeler P.D., and Cook P.D. J. Med. Cem. 39 (1996) 5100
42. Lima W.F., and Crooke S.T. Biochemistry 36 2 (1997) 390
43. Crooke S.T., Lemonidis K.M., Neilson L., Griffey R., Lesnik E.A., and Monia B.P. J. Biochem. 312 (1995) 599
44. Cook P.D. In: Crooke S.T., and Lebleu B. (Eds). "Antisense Research and Applications (1993), CRC Press, Boca Raton, FL 149-187
45. Monia B.P., Lesnik E.A., Gonzalez C., Lima W.F., McGee D., Guinosso C.J., Kawasaki A.M., Cook P.D., and Freier S.M. J. Biol. Chem. 268 (1993) 14514
46. Yu D., Iyer R.P., Shaw D.R., Lisziewicz J., Li Y., Jiang Z., Roskey A., and Agrawal S. Bioorg. Med.Chem. 4 (1996) 1685
47. Hoke G.D., Draper K., Freier S.M., Gonzalez C., Driver V.B., and Zounes M.C. Nucleic Acids Res. 19 (1991) 5743
48. Dagle J.M., Andracki M.E., DeVine R.J., and Walder J.A. Nucleic Acids Res. 19 (1991) 1805
49. Agrawal S., Mayrand S.H., Zamecnik P.C., and Pederson T. Proc. Natl.Acad. Sci. USA 87 (1990) 1401
50. Guinosso C.J., Hoke G.D., Freier S.M., Martin J.F., Ecker D.J., Mirabelli C.K., Crooke S.T., and Cook P.D. Nucleoside Nucleotides 10 (1991) 259
51. Kawasaki A.M., Casper M.D., Freier S.M., Lesnik E.A., Zounes M.C., Cummins L.L., Gonzalez C., and Cook P.D. J. Med. Chem. 36 (1993) 831
52. Miller P.S., Bhan P., Cushman C.D., Kean J.M., and Levis J.T. Nucleosides Nucleotides 10 (1991) 37
53. Sproat B.S., Lamond A.I., Beijer B., Neuner P., and Ryder U. Nucleic Acids Res. 17 (1989) 3373
54. Sproat B.S., Lamond A.I., Beijer B., Neuner P., and Ryder U. chap. 18. In: Crooke S.T., and Lebleu B. (Eds). "Antisense Research and Aplications" (1993), CRC Press, Boca Raton, FL
55. Morvan F., Porumb H., Degols G., Lefebvre I., Pompon A., Sproat S., Rayner B., Malvy C., Lebleu B., and Imbach J.-L. J. Med. Chem. 36 (1993) 280
56. Sands H., Gorey-Feret L.J., Ho S.P., Bao Y., Cocuzza A.J., Chidester D., and Hobbs F.W. Amer. Soc.Pharm. Exper. Therapeutics 47 (1995) 636
57. Heidenreich O., Gryaznov S., and Nerenberg M. Nucleic Acids Res. 25 (1997) 776
58. Monia B.P., Johnston J.F., Sasmor H., and Cummins L.L. J. Biol. Chem. 271 (1996) 14533
59. Lima W.F., Mohan V., and Crooke S.T. J. Biol. Chem. 272 29 (1997) 18191
60. Baker B.F., Lot S., Condon T.P., Cheng-Flourney S., Lesnik E., Sasmor H., and Bennett C.F. J. Biol. Chem. 272 (1997) 11994
61. Crooke S.T., Graham M.J., Zuckerman J.E., Brooks D., Conklin B.S., Cummins L.L., Greig M.J., Guinosso C.J., Kornbrust D., Manoharan M., Sasmor H.M., Schleich T., Tivel K.L., and Griffey R.H. J. Pharm. Exper.Therapeutics 277 (1996) 923
62. Nicklin P.L., Ambler J., Mitchelson A., Bayley D., Phillips J.A., Craig S.J., and Monia B.P. Nucleosides Nucleotides 16 (1997) 1145
63. Hughes J.A., Bennett C.F., Cook P.D., Guinosso C.J., Mirabelli C.K., and Juliano R.L. J. Pharmaceutical Sci. 83 (1993) 597
64. Hughes J., Avroutskaya A., Sasmor H.M., Guinosso C.J., Cook P.D., and Juliano R.L. In: Akhtar S. (Ed). Delivery Strategies for Antisense Oligonucleotide Therapeutics (1995), CRC Press, Boca Raton, FL